GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (XPAR:ALEMG) » Definitions » YoY EBITDA Growth

Labo Euromedis (XPAR:ALEMG) YoY EBITDA Growth : 5.91% (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Labo Euromedis YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Labo Euromedis's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 5.91%.

Labo Euromedis's EBITDA per Share for the six months ended in Jun. 2023 was €-1.13.


Labo Euromedis YoY EBITDA Growth Historical Data

The historical data trend for Labo Euromedis's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis YoY EBITDA Growth Chart

Labo Euromedis Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -185.44 1,756.17 -87.27 -201.73 726.68

Labo Euromedis Semi-Annual Data
Jul13 Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -118.13 -141.87 115.91 5.91 4,184.38

Labo Euromedis YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Labo Euromedis's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-1.233-1.212)/ | 1.212 |
=-201.73 %

Labo Euromedis's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(-1.131--1.202)/ | -1.202 |
=5.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Labo Euromedis YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Labo Euromedis (XPAR:ALEMG) Business Description

Traded in Other Exchanges
Address
ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290
Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (XPAR:ALEMG) Headlines

No Headlines